+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report by Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), by End-use (Hospitals & Diagnostic Laboratories, Academic & Research Institutes), by Region and Segment Forecasts, 2025-2033

  • PDF Icon

    Report

  • 150 Pages
  • August 2025
  • Region: Global
  • Grand View Research
  • ID: 4751806
Description Jump to:
The global liver cancer diagnostics market size was estimated at USD 9.99 billion in 2024 and is projected to reach USD 17.57 billion by 2033, growing at a CAGR of 6.42% from 2025 to 2033. Liver cancer is the leading cause of death amongst all deadly diseases in the globe.

Since 1980, the rate of incidence of liver cancer has tripled and death rates have doubled during this period. The American Cancer Society estimated that in 2025, about 42,240 new cases are expected, and about 30,090 people will succumb to death. Thus, the global rise in liver cancer prevalence, combined with ongoing exposure to risk factors, will significantly accelerate the growth of the screening and diagnosis market. The rising incidence of liver cancer is increasing the demand for early-stage cancer diagnosis and efforts to reduce associated risk factors. Early detection is crucial in lowering cancer-related deaths, especially through effective screening programs. Overall, diagnosing cancer early can boost patient survival rates by 5 to 10 times compared to later detection.

As the global cases of liver cancer grow, the need for early detection tools and screening methods has intensified. For instance, the National Cancer Institute established the Liver (Hepatocellular) Cancer Screening (PDQ)-health professional version program in April 2025, utilizing techniques like needle aspiration cytology and trans jugular liver biopsy. Programs focused on high-risk groups, such as those with chronic liver conditions, are promoting greater awareness and use of diagnostic tools like ultrasound, CT scans, and blood tests. Early and regular screenings improve detection rates and patient outcomes. This increased emphasis on prevention and early diagnosis is driving innovations in liver cancer diagnostics and accelerating market growth.

Liver cancer screening and treatment are poised for a major shift thanks to cutting-edge early screening technologies currently in advanced development stages. These new innovations are paving the way for growth in the liver diagnostics market. For instance, in April 2025, the FDA granted breakthrough device designation to the EvoLiver biopsy test for monitoring hepatocellular carcinoma (HCC) in patients with high-risk cirrhosis. The test uses a multiomics biomarker signature based on extracellular vesicles (EV) and has shown promising results in detecting early-stage HCC. Data from the MEV01 trial, which involved 464 patient samples, indicated that the EvoLiver test achieved an impressive 86% sensitivity and 88% specificity for early-stage HCC detection. These results significantly surpass current surveillance methods like ultrasound and alpha-fetoprotein testing. This innovative approach has the potential to improve the management of hepatocellular carcinoma in cirrhotic patients greatly.

Global Liver Cancer Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. The analyst has segmented the global liver cancer diagnostics market report on the basis of test type, end-use, and region:

Test type Outlook (Revenue, USD Million, 2021-2033)

  • Laboratory Tests
  • Biomarkers
  • Oncofetal and Glycoprotein Antigens
  • Enzymes and Isoenzymes
  • Growth Factors and Receptors
  • Molecular Markers
  • Pathological Biomarkers
  • Blood Tests
  • Imaging
  • Endoscopy
  • Biopsy

End-use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals & Diagnostic Laboratories
  • Academic & Research Institutes
  • Pharmaceutical & CRO Laboratories
  • Regional Outlook (Revenue in USD Million, 2021-2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Test type
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test type outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Liver Cancer Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing Incidence of Liver Cancer
3.2.1.2. Technological Advancements
3.2.1.3. Extensive R&D for Developing Novel Testing Solutions
3.2.2. Market restraint analysis
3.2.2.1. High Cost of Diagnostic imaging
3.3. Liver Cancer Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Liver Cancer Diagnostics Market: Test type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Liver Cancer Diagnostics Market: Product Movement Analysis
4.3. Liver Cancer Diagnostics Market Size & Trend Analysis, by test type, 2021 to 2033 (USD Million)
4.3.1. Global Laboratory Tests Market, 2021-2033 (USD MILLION)
4.3.1.1. Biomarkers
4.3.1.1.1. Global biomarkers market, 2021-2033 (USD million)
4.3.1.1.1.1. Oncofetal and Glycoprotein Antigens
4.3.1.1.1.1.1. Global oncofetal and glycoprotein antigens market, 2021-2033 (USD million)
4.3.1.1.1.2. Enzymes and Isoenzymes
4.3.1.1.1.2.1. Global enzymes and isoenzymes market, 2021-2033 (USD million)
4.3.1.1.1.3. Growth Factors and Receptors
4.3.1.1.1.3.1. Global growth factors and receptors market, 2021-2033 (USD million)
4.3.1.1.1.4. Molecular Markers
4.3.1.1.1.4.1. Global molecular markers market, 2021-2033 (USD million)
4.3.1.1.1.5. Pathological Biomarkers
4.3.1.1.1.5.1. Global pathological biomarkers market, 2021-2033 (USD million)
4.3.1.2. Blood Tests
4.3.1.2.1. Global blood tests market, 2021-2033 (USD million)
4.3.2. Imaging
4.3.2.1. Global Imaging Market, 2021-2033 (USD MILLION)
4.3.3. Endoscopy
4.3.3.1. Global Endoscopy Market, 2021-2033 (USD MILLION)
4.3.4. Biopsy
4.3.4.1. Global Biopsy Market, 2021-2033 (USD MILLION)
Chapter 5. Liver Cancer Diagnostics Market: End Use Estimates & Trend Analysis
5.1. End Use Market Share, 2024 & 2033
5.2. Segment Dashboard
5.3. Global Liver Cancer Diagnostics Market by End Use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Hospitals & Diagnostic Laboratories
5.5.1. Global Hospitals & Diagnostic Laboratories market, 2021-2033 (USD Million)
5.6. Academic & Research Institutes
5.6.1. Global Academic & Research Institutes Market, 2021-2033 (USD million)
5.7. Pharmaceutical & CRO Laboratories
5.7.1. Global Pharmaceutical & CRO Laboratories market, 2021-2033 (USD million)
Chapter 6. Liver Cancer Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2033
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
6.5. North America
6.5.1. North America: SWOT Analysis
6.5.2. U.S.
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/Reimbursement
6.5.2.3. Competitive scenario
6.5.2.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
6.5.3. Canada
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/Reimbursement
6.5.3.3. Competitive scenario
6.5.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
6.5.4. Mexico
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/Reimbursement
6.5.4.3. Competitive scenario
6.5.4.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Europe
6.6.1. Europe: SWOT Analysis
6.6.2. UK
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/Reimbursement
6.6.2.3. Competitive scenario
6.6.2.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
6.6.3. Germany
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/Reimbursement
6.6.3.3. Competitive scenario
6.6.3.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
6.6.4. France
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/Reimbursement
6.6.4.3. Competitive scenario
6.6.4.4. France market estimates and forecasts 2021 to 2033 (USD Million)
6.6.5. Italy
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/Reimbursement
6.6.5.3. Competitive scenario
6.6.5.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
6.6.6. Spain
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/Reimbursement
6.6.6.3. Competitive scenario
6.6.6.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
6.6.7. Norway
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/Reimbursement
6.6.7.3. Competitive scenario
6.6.7.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
6.6.8. Sweden
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/Reimbursement
6.6.8.3. Competitive scenario
6.6.8.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
6.6.9. Denmark
6.6.9.1. Key country dynamics
6.6.9.2. Regulatory framework/Reimbursement
6.6.9.3. Competitive scenario
6.6.9.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
6.7. Asia-Pacific
6.7.1. Asia-Pacific: SWOT Analysis
6.7.2. Japan
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/Reimbursement
6.7.2.3. Competitive scenario
6.7.2.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
6.7.3. China
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/Reimbursement
6.7.3.3. Competitive scenario
6.7.3.4. China market estimates and forecasts 2021 to 2033 (USD Million)
6.7.4. India
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/Reimbursement
6.7.4.3. Competitive scenario
6.7.4.4. India market estimates and forecasts 2021 to 2033 (USD Million)
6.7.5. Australia
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/Reimbursement
6.7.5.3. Competitive scenario
6.7.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
6.7.6. South Korea
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/Reimbursement
6.7.6.3. Competitive scenario
6.7.6.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
6.7.7. Thailand
6.7.7.1. Key country dynamics
6.7.7.2. Regulatory framework/Reimbursement
6.7.7.3. Competitive scenario
6.7.7.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
6.8. Latin America
6.8.1. Latin America: SWOT Analysis
6.8.2. Brazil
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/Reimbursement
6.8.2.3. Competitive scenario
6.8.2.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
6.8.3. Argentina
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/Reimbursement
6.8.3.3. Competitive scenario
6.8.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
6.9. MEA
6.9.1. MEA: SWOT Analysis
6.9.2. South Africa
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/Reimbursement
6.9.2.3. Competitive scenario
6.9.2.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
6.9.3. Saudi Arabia
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/Reimbursement
6.9.3.3. Competitive scenario
6.9.3.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
6.9.4. UAE
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework/Reimbursement
6.9.4.3. Competitive scenario
6.9.4.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
6.9.5. Kuwait
6.9.5.1. Key country dynamics
6.9.5.2. Regulatory framework
6.9.5.3. Competitive scenario
6.9.5.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, by Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2024
7.3.4. Abbott Laboratories
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Services benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Thermo Fisher Scientific, Inc.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Services benchmarking
7.3.5.4. Strategic initiatives
7.3.6. F. Hoffmann-La Roche Ltd.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Services benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Qiagen N.V.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Services benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Siemens Healthineers
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Services benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Becton, Dickinson & Company
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Services benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Illumina, Inc.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Services benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Epigenomics AG
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Services benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Koninklijke Philips N.V.
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Services benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Fujifilm Medical Systems U.S.a., Inc.
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Services benchmarking
7.3.13.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America Liver cancer diagnostics market, by region, 2021-2033 (USD Million)
Table 3 North America Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 4 North America Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 5 U.S Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 6 U.S Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 7 Canada Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 8 Canada Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 9 Mexico Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 10 Mexico Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 11 Europe Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 12 Europe Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 13 UK Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 14 UK Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 15 Germany Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 16 Germany Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 17 France Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 18 France Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 19 Italy Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 20 Italy Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 21 Spain Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 22 Spain Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 23 Denmark Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 24 Denmark Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 25 Sweden Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 26 Sweden Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 27 Norway Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 28 Norway Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 29 Asia-Pacific Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 30 Asia-Pacific Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 31 Japan Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 32 Japan Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 33 China Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 34 China Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 35 India Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 36 India Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 37 Australia Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 38 Australia Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 39 South Korea Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 40 South Korea Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 41 Thailand Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 42 Thailand Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 43 Latin America Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 44 Latin America Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 45 Brazil Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 46 Brazil Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 47 Argentina Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 48 Argentina Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 49 MEA Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 50 MEA Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 51 South Africa Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 52 South Africa Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 53 Saudi Arabia Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 54 Saudi Arabia Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 55 UAE Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 56 UAE Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
Table 57 Kuwait Liver cancer diagnostics market, by test type, 2021-2033 (USD Million)
Table 58 Kuwait Liver cancer diagnostics market, by end use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews in North America
Figure 5 Primary interviews in Europe
Figure 6 Primary interviews in APAC
Figure 7 Primary interviews in Latin America
Figure 8 Primary interviews in MEA
Figure 9 Market research approaches
Figure 10 Value-chain-based sizing & forecasting
Figure 11 QFD modeling for market share assessment
Figure 12 Market formulation & validation
Figure 13 Liver cancer diagnostics market: market outlook
Figure 14 Liver cancer diagnostics competitive insights
Figure 15 Parent market outlook
Figure 16 Related/ancillary market outlook
Figure 17 Penetration and growth prospect mapping
Figure 18 Industry value chain analysis
Figure 19 Liver cancer diagnostics market driver impact
Figure 20 Liver cancer diagnostics market restraint impact
Figure 21 Liver cancer diagnostics market strategic initiatives analysis
Figure 22 Liver cancer diagnostics market: Test type movement analysis
Figure 23 Liver cancer diagnostics market: Test type outlook and key takeaways
Figure 24 Laboratory Tests Liver Cancer Diagnostics market estimates and forecast, 2021-2033
Figure 25 Imaging Liver Cancer Diagnostics estimates and forecast, 2021-2033
Figure 26 Endoscopy Liver Cancer Diagnostics market estimates and forecast, 2021-2033
Figure 27 Biopsy Liver Cancer Diagnostics market estimates and forecast, 2021-2033
Figure 28 Others Liver Cancer Diagnostics market estimates and forecast, 2021-2033
Figure 29 Liver cancer diagnostics market: End Use movement analysis
Figure 30 Liver cancer diagnostics market: End Use outlook and key takeaways
Figure 31 Hospitals & Diagnostic Laboratories market estimates and forecasts, 2021-2033
Figure 32 Academic and Research Institutes market estimates and forecasts, 2021-2033
Figure 33 Pharmaceutical & CRO Laboratories market estimates and forecasts, 2021-2033
Figure 34 Global Liver cancer diagnostics market: Regional movement analysis
Figure 35 Global Liver cancer diagnostics market: Regional outlook and key takeaways
Figure 36 Global Liver cancer diagnostics market share and leading players
Figure 37 North America market share and leading players
Figure 38 Europe market share and leading players
Figure 39 Asia-Pacific market share and leading players
Figure 40 Latin America market share and leading players
Figure 41 Middle East & Africa market share and leading players
Figure 42 North America, by country
Figure 43 North America
Figure 44 North America market estimates and forecasts, 2021-2033
Figure 45 U.S.
Figure 46 U.S. market estimates and forecasts, 2021-2033
Figure 47 Canada
Figure 48 Canada market estimates and forecasts, 2021-2033
Figure 49 Mexico
Figure 50 Mexico market estimates and forecasts, 2021-2033
Figure 51 Europe
Figure 52 Europe market estimates and forecasts, 2021-2033
Figure 53 UK
Figure 54 UK market estimates and forecasts, 2021-2033
Figure 55 Germany
Figure 56 Germany market estimates and forecasts, 2021-2033
Figure 57 France
Figure 58 France market estimates and forecasts, 2021-2033
Figure 59 Italy
Figure 60 Italy market estimates and forecasts, 2021-2033
Figure 61 Spain
Figure 62 Spain market estimates and forecasts, 2021-2033
Figure 63 Denmark
Figure 64 Denmark market estimates and forecasts, 2021-2033
Figure 65 Sweden
Figure 66 Sweden market estimates and forecasts, 2021-2033
Figure 67 Norway
Figure 68 Norway market estimates and forecasts, 2021-2033
Figure 69 Asia-Pacific
Figure 70 Asia-Pacific market estimates and forecasts, 2021-2033
Figure 71 China
Figure 72 China market estimates and forecasts, 2021-2033
Figure 73 Japan
Figure 74 Japan market estimates and forecasts, 2021-2033
Figure 75 India
Figure 76 India market estimates and forecasts, 2021-2033
Figure 77 Thailand
Figure 78 Thailand market estimates and forecasts, 2021-2033
Figure 79 South Korea
Figure 80 South Korea market estimates and forecasts, 2021-2033
Figure 81 Australia
Figure 82 Australia market estimates and forecasts, 2021-2033
Figure 83 Latin America
Figure 84 Latin America market estimates and forecasts, 2021-2033
Figure 85 Brazil
Figure 86 Brazil market estimates and forecasts, 2021-2033
Figure 87 Argentina
Figure 88 Argentina market estimates and forecasts, 2021-2033
Figure 89 Middle East and Africa
Figure 90 Middle East and Africa market estimates and forecasts, 2021-2033
Figure 91 South Africa
Figure 92 South Africa market estimates and forecasts, 2021-2033
Figure 93 Saudi Arabia
Figure 94 Saudi Arabia market estimates and forecasts, 2021-2033
Figure 95 UAE
Figure 96 UAE market estimates and forecasts, 2021-2033
Figure 97 Kuwait
Figure 98 Kuwait market estimates and forecasts, 2021-2033
Figure 99 Market share of key market players- Liver cancer diagnostics market

Companies Mentioned

The major companies profiled in this Liver Cancer Diagnostics market report include:
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Qiagen N.V.
  • Siemens Healthineers
  • Becton, Dickinson & Company
  • Illumina, Inc.
  • Epigenomics AG
  • Koninklijke Philips N.V.
  • Fujifilm Medical Systems U.S.A., Inc.

Table Information

Report AttributeDetails
No. of Pages150
PublishedAugust 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 9.99 Billion
Forecasted Market Value ( USD ) by 2033 $ 17.57 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Liver Cancer Diagnostics Market - Global Forecast 2025-2030 - Product Image

Liver Cancer Diagnostics Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Liver Disease Diagnostics Market Size, Share & Trends Analysis Report by Diagnosis Technique (Imaging, Laboratory Tests, Endoscopy, Biopsy), by Disease (NAFLD, NASH, Fibrosis, Cirrhosis), by End Use (Hospitals, Laboratories), by Region, and Segment Forecasts, 2025-2033 - Product Image

Liver Disease Diagnostics Market Size, Share & Trends Analysis Report by Diagnosis Technique (Imaging, Laboratory Tests, Endoscopy, Biopsy), by Disease (NAFLD, NASH, Fibrosis, Cirrhosis), by End Use (Hospitals, Laboratories), by Region, and Segment Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Global
From
Liver Cancer Diagnostics - Global Strategic Business Report - Product Image

Liver Cancer Diagnostics - Global Strategic Business Report

  • Report
  • 275 Pages
  • Global
From
Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Type (IVD, LDT, Imaging), By Application (Breast Cancer, Lung Cancer), By End-use, By Test Type, By Coverage, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Type (IVD, LDT, Imaging), By Application (Breast Cancer, Lung Cancer), By End-use, By Test Type, By Coverage, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 200 Pages
  • Global
From
Liver Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Liver Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.